{"id":"https://openalex.org/W4393085485","doi":"https://doi.org/10.1158/1538-7445.am2024-6352","title":"Abstract 6352: Preclinical discovery of ARX622: A site-specific, TLR7 agonist, HER2-targeted immune-stimulatory antibody drug conjugate for treatment of multiple solid tumor types","display_name":"Abstract 6352: Preclinical discovery of ARX622: A site-specific, TLR7 agonist, HER2-targeted immune-stimulatory antibody drug conjugate for treatment of multiple solid tumor types","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393085485","doi":"https://doi.org/10.1158/1538-7445.am2024-6352"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-6352","doi":"https://doi.org/10.1158/1538-7445.am2024-6352","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-6352","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David Mills","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Mills","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051891248","display_name":"Ji Young Kim","orcid":"https://orcid.org/0009-0004-8046-9438","observed_orcids":["https://orcid.org/0009-0004-8046-9438"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ji Young Kim","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054120578","display_name":"Erica M. Wood","orcid":"https://orcid.org/0000-0001-7527-2340","observed_orcids":["https://orcid.org/0000-0001-7527-2340"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica Wood","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061647857","display_name":"Keith J. Tatsukawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Tatsukawa","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031305401","display_name":"Nick A. Knudsen","orcid":"https://orcid.org/0009-0004-7026-0366","observed_orcids":["https://orcid.org/0009-0004-7026-0366"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nick Knudsen","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jay Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay Nelson","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034466570","display_name":"Lillian K. Skidmore","orcid":"https://orcid.org/0009-0005-8277-8223","observed_orcids":["https://orcid.org/0009-0005-8277-8223"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lillian Skidmore","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094221961","display_name":"Kedar GC","orcid":"https://orcid.org/0009-0005-5332-2155","observed_orcids":["https://orcid.org/0009-0005-5332-2155"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kedar GC","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007386554","display_name":"Hon Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hon Tran","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065954633","display_name":"Manoj  Kumar Pal","orcid":"https://orcid.org/0000-0001-9152-1028","observed_orcids":["https://orcid.org/0000-0001-9152-1028"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manoj Pal","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115593090","display_name":"Hamidreza Hashemi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hamidreza Hashemi","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026631878","display_name":"Ying Ji Buechler","orcid":"https://orcid.org/0009-0002-3117-0929","observed_orcids":["https://orcid.org/0009-0002-3117-0929"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Buechler","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078194618","display_name":"Shawn Zhang","orcid":"https://orcid.org/0000-0002-8068-673X","observed_orcids":["https://orcid.org/0000-0002-8068-673X"]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn Zhang","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]},{"author_position":"last","author":{"id":null,"display_name":"Dan O'Connor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107392","display_name":"Ambrx (United States)","ror":"https://ror.org/01r1pft76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210107392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan O'Connor","raw_affiliation_strings":["1Ambrx, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ambrx, San Diego, CA","institution_ids":["https://openalex.org/I4210107392"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210107392"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"6352","last_page":"6352"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.04580000042915344,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.024800000712275505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tlr7-agonist","display_name":"TLR7 agonist","score":0.8820000290870667},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.8529999852180481},{"id":"https://openalex.org/keywords/drug-to-antibody-ratio","display_name":"drug-to-antibody ratio","score":0.8740000128746033},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8299999833106995},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.7020000219345093},{"id":"https://openalex.org/keywords/antigen-presenting-cell-maturation","display_name":"antigen-presenting cell maturation","score":0.8180000185966492},{"id":"https://openalex.org/keywords/immunological-memory","display_name":"immunological memory","score":0.6909999847412109},{"id":"https://openalex.org/keywords/epitope-spreading","display_name":"epitope spreading","score":0.8349999785423279},{"id":"https://openalex.org/keywords/her2-low-tumors","display_name":"HER2-low tumors","score":0.7710000276565552},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7590000033378601},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7347772121429443},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.658280611038208},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6089179515838623},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5820871591567993},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5540835857391357},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5499888062477112},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5379775762557983},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5348225235939026},{"id":"https://openalex.org/C2779836521","wikidata":"https://www.wikidata.org/wiki/Q14914081","display_name":"TLR7","level":5,"score":0.5139712691307068},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.4914644956588745},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3673797845840454},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33239781856536865},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2945614457130432},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2717893123626709},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.18345999717712402},{"id":"https://openalex.org/C2776709828","wikidata":"https://www.wikidata.org/wiki/Q408004","display_name":"Toll-like receptor","level":4,"score":0.10716524720191956},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.07744225859642029},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-6352","doi":"https://doi.org/10.1158/1538-7445.am2024-6352","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-6352","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282936598","https://openalex.org/W3111948793","https://openalex.org/W4297874939","https://openalex.org/W3034156764","https://openalex.org/W1651223554","https://openalex.org/W3098911732","https://openalex.org/W4308383460","https://openalex.org/W4377141782","https://openalex.org/W4404052751","https://openalex.org/W7115619619"],"abstract_inverted_index":{"Abstract":[0],"Traditional":[1],"antibody-drug":[2],"conjugates":[3,32],"leverage":[4],"the":[5,44,56,95,111,198,204,415],"specificity":[6],"of":[7,29,53,58,87,100,114,206,244,249,284,316,356,393,406,414],"antibodies":[8],"to":[9,13,37,43,66,75,132,150,191],"deliver":[10,39],"cytotoxic":[11,151],"payloads":[12,64],"tumor":[14,227,232,257,278,409],"microenvironments":[15],"(TMEs),":[16],"thereby":[17],"reducing":[18],"systemic":[19,47],"toxicities":[20],"associated":[21],"with":[22,267,291,336,353],"non-targeted":[23],"chemotherapeutics.":[24],"Analogously,":[25],"a":[26,102,122,133,192,225,292,344,354],"novel":[27],"class":[28],"immune-stimulating":[30],"antibody":[31,81,200,401],"(ISACs)":[33],"has":[34,121,311],"recently":[35],"emerged":[36],"selectively":[38,210],"synthetic":[40,134],"immune":[41,48,326],"agonists":[42],"TME":[45],"without":[46],"activation.":[49],"The":[50],"first":[51],"generation":[52,96,116],"ISACs":[54],"and":[55,60,83,97,118,124,161,177,201,217,221,236,254,280,303,338],"majority":[57],"approved":[59],"investigational":[61],"ADCs":[62,117,152],"contain":[63],"linked":[65],"native":[67],"lysine":[68],"or":[69,270,333],"cysteine":[70,195],"residues,":[71],"which":[72,88,140],"can":[73],"lead":[74],"heterogenous":[76],"drug-antibody":[77],"ratios":[78],"(DARs),":[79],"reduced":[80],"stability,":[82,324],"labile":[84],"conjugation,":[85],"all":[86],"limit":[89],"therapeutic":[90,314,340],"index.":[91],"Here":[92],"we":[93],"describe":[94],"preclinical":[98],"characterization":[99],"ARX622,":[101],"site-specific":[103,156],"TLR7-selective":[104],"agonist":[105],"ISAC":[106,160,196],"targeting":[107],"HER2.":[108],"To":[109],"avoid":[110],"instability":[112],"issues":[113],"previous":[115],"ISACs,":[119],"ARX622":[120,159,182,209,229,245,275,310],"homogenous":[123],"stable":[125],"DAR":[126],"via":[127],"oxime":[128],"bond-mediated":[129],"payload":[130,179],"conjugation":[131,157],"amino":[135],"acid,":[136],"para-acetyl":[137],"phenylalanine":[138],"(pAF),":[139],"is":[141],"recombinantly":[142],"incorporated":[143],"at":[144,298],"defined":[145],"heavy":[146],"chain":[147],"positions.":[148],"Similar":[149],"built":[153],"on":[154,295],"this":[155],"platform,":[158],"total":[162],"mAb":[163],"pharmacokinetic":[164],"(PK)":[165],"profiles":[166],"in":[167,174,188,259,301,306,334],"non-human":[168],"primates":[169],"(NHPs)":[170],"are":[171],"indistinguishable,":[172],"demonstrating":[173],"vivo":[175],"stability":[176],"minimal":[178],"deconjugation.":[180],"Accordingly,":[181],"displays":[183],"an":[184,312],"extended":[185],"PK":[186,296],"profile":[187],"mice":[189,260,302],"compared":[190],"DAR-matched":[193],"random":[194],"containing":[197],"same":[199],"payload.":[202],"In":[203,224,239,272],"presence":[205],"HER2-expressing":[207,357],"cells,":[208],"induces":[211],"proinflammatory":[212],"cytokine":[213],"production,":[214],"type":[215],"I":[216],"III":[218],"IFN":[219],"secretion,":[220],"APC":[222],"maturation.":[223],"syngeneic":[226],"model,":[228],"promotes":[230,281],"complete":[231,247,282],"regressions,":[233],"immunologic":[234],"memory,":[235],"epitope":[237],"spreading.":[238],"xenograft":[240],"systems,":[241],"single":[242],"doses":[243,300],"induce":[246],"regression":[248,283],"large,":[250],"established":[251],"tumors":[252,287],"(>1000mm3),":[253],"robustly":[255],"inhibit":[256],"growth":[258],"that":[261],"have":[262],"progressed":[263],"through":[264],"prior":[265],"treatment":[266,405],"HER2-targeted":[268,399],"mAbs":[269],"ADCs.":[271],"HER2-low":[273],"xenografts,":[274],"monotherapy":[276],"inhibits":[277],"growth,":[279],"late-stage":[285],"(800mm3)":[286],"when":[288],"sequentially":[289],"combined":[290],"HER2-ADC.":[293],"Based":[294],"data":[297],"efficacious":[299],"tolerated":[304],"exposures":[305],"NHP":[307],"toxicity":[308],"studies,":[309],"estimated":[313],"index":[315,341],"~60x.":[317],"Taken":[318],"together,":[319],"ARX622\u2019s":[320],"mAb-like":[321],"properties,":[322],"high":[323],"broad":[325],"mechanism":[327],"induction,":[328],"strong":[329,345],"anti-tumor":[330],"activity":[331],"alone":[332],"combination":[335],"ADCs,":[337],"wide":[339],"make":[342],"it":[343],"candidate":[346],"for":[347,404,418],"further":[348],"development":[349],"toward":[350],"treating":[351],"patients":[352],"variety":[355],"solid":[358,408],"tumors.":[359],"Citation":[360],"Format:":[361],"David":[362],"Mills,":[363],"Ji":[364],"Young":[365],"Kim,":[366],"Erica":[367],"Wood,":[368],"Keith":[369],"Tatsukawa,":[370],"Nick":[371],"Knudsen,":[372],"Jay":[373],"Nelson,":[374],"Lillian":[375],"Skidmore,":[376],"Kedar":[377],"GC,":[378],"Hon":[379],"Tran,":[380],"Manoj":[381],"Pal,":[382],"Hamidreza":[383],"Hashemi,":[384],"Ying":[385],"Buechler,":[386],"Shawn":[387],"Zhang,":[388],"Dan":[389],"O'Connor.":[390],"Preclinical":[391],"discovery":[392],"ARX622:":[394],"A":[395],"site-specific,":[396],"TLR7":[397],"agonist,":[398],"immune-stimulatory":[400],"drug":[402],"conjugate":[403],"multiple":[407],"types":[410],"[abstract].":[411],"In:":[412],"Proceedings":[413],"American":[416],"Association":[417],"Cancer":[419,437],"Research":[420],"Annual":[421],"Meeting":[422],"2024;":[423],"Part":[424],"1":[425],"(Regular":[426],"Abstracts);":[427],"2024":[428],"Apr":[429],"5-10;":[430],"San":[431],"Diego,":[432],"CA.":[433],"Philadelphia":[434],"(PA):":[435],"AACR;":[436],"Res":[438],"2024;84(6_Suppl):Abstract":[439],"nr":[440],"6352.":[441]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2024-03-23T00:00:00"}